Skip to main content

Table 3 Results from multivariate cox regression of survival parameters

From: Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis

Parameter influencing overall survival

HR

95% CI

p

Pt. on aspirin (yes vs. no)

0.357

0.149–0.856

*0.021

Not included

   

 Vascular invasion (yes vs. no)

  

0.228

 Serum CA19-9 above median

  

0.490

 Lymphovascular invasion

  

0.440

 Adjuvant chemotherapy

  

0.061

Parameter influencing disease-free survival

 Pt. on aspirin (yes vs. no)

0.316

0.158–0.634

**0.001

 Vascular invasion (yes vs. no)

3.008

1.541–5.871

**0.001

 Not included

   

  Tumor diameter (> median vs. ≤ median)

  

0.081

  Lymphovascular invasion

  

0.484

Parameter influencing hematogenous-met-free survival

   

 Pt. on aspirin (yes vs. no)

0.354

0.162–0.772

*0.009

 Vascular invasion (yes vs. no)

4.330

2.006–9.344

**< 0.001

  Not included

   

  Tumor diameter (> median vs. ≤ median)

  

0.065

  Lymphovascular invasion

  

0.258